Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1042 | 1055 | 1057 | 1112 | 1147 | 1565 |
Fund Return | 4.19% | 5.47% | 5.73% | 3.61% | 2.78% | 4.58% |
Place in category | 504 | 478 | 456 | 447 | 405 | 276 |
% in Category | 79 | 76 | 75 | 82 | 90 | 81 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UK Equity Income Fund Institutional | 94.51M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Retail Income | 144.92M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Z Accumulatio | 758.13M | 1.50 | 7.38 | 6.41 | ||
UK Equity Income Fund Z Income GBP | 702.41M | 1.50 | 7.39 | 6.42 | ||
UK Equity Income Fund Retail Accumu | 121.28M | 1.44 | 5.44 | 5.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.23B | 6.08 | 7.20 | 5.78 | ||
All Share Index Unit Trust Income | 14.23B | -0.70 | 7.89 | - | ||
VG UK Plus GBP Accumulation | 14.23B | -0.70 | 7.91 | - | ||
VG UK Institutional Plus GBP Income | 14.23B | -0.69 | 7.90 | - | ||
UK Equity Tracker Fund D Acc | 11.62B | 6.08 | 7.79 | 5.93 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 7.71 | 33.94 | -1.15% | |
AstraZeneca | GB0009895292 | 5.46 | 12,246.0 | -0.59% | |
Relx | GB00B2B0DG97 | 4.69 | 3,444.00 | +0.97% | |
GSK plc | GB00BN7SWP63 | 3.77 | 1,810.00 | 0.00% | |
Compass | GB00BD6K4575 | 3.75 | 2,321.00 | +0.61% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review